Current concepts in molecular genetics and management guidelines for pancreatic cystic neoplasms: an essential update for radiologists

Matthew Kulzer, Aatur D. Singhi, Alessandro Furlan, Matthew T. Heller, Venkata S. Katabathina, Kevin M. Mcgrath, Herbert J. Zeh, Amer Zureikat, Anil K. Dasyam

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Cystic neoplasms in the pancreas are encountered frequently on imaging, often detected incidentally during evaluation for other conditions. They can have a variety of clinical and imaging presentations, and similarly, wide-ranging prognostic and treatment implications. In the majority, imaging helps in diagnosis of pancreatic cystic neoplasms (PCNs) and guides management decisions. But, a significant minority of the PCNs remain indeterminate. There have been multiple recent advances in biomarkers and molecular genetics which will likely prove helpful in risk stratification of PCNs. Several prominent national and international societies, as well as consensus groups have put forth recommendations to help guide management of PCNs. The purpose of this article is to discuss the role of imaging in evaluation of PCNs, review the recent advances in molecular genetics and pancreatic cyst fluid analysis, and analyze the pros and cons of major evidence-based and consensus guidelines for management of PCNs.

Original languageEnglish (US)
Pages (from-to)2351-2368
Number of pages18
JournalAbdominal Radiology
Volume43
Issue number9
DOIs
StatePublished - Sep 1 2018
Externally publishedYes

Fingerprint

Pancreatic Neoplasms
Molecular Biology
Guidelines
Pancreatic Cyst
Cyst Fluid
Radiologists
Biomarkers

Keywords

  • IPMN
  • Mucinous cystadenoma
  • Pancreatic cystic neoplasm
  • Serous cystadenoma

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging
  • Gastroenterology
  • Urology

Cite this

Kulzer, M., Singhi, A. D., Furlan, A., Heller, M. T., Katabathina, V. S., Mcgrath, K. M., ... Dasyam, A. K. (2018). Current concepts in molecular genetics and management guidelines for pancreatic cystic neoplasms: an essential update for radiologists. Abdominal Radiology, 43(9), 2351-2368. https://doi.org/10.1007/s00261-017-1452-5

Current concepts in molecular genetics and management guidelines for pancreatic cystic neoplasms : an essential update for radiologists. / Kulzer, Matthew; Singhi, Aatur D.; Furlan, Alessandro; Heller, Matthew T.; Katabathina, Venkata S.; Mcgrath, Kevin M.; Zeh, Herbert J.; Zureikat, Amer; Dasyam, Anil K.

In: Abdominal Radiology, Vol. 43, No. 9, 01.09.2018, p. 2351-2368.

Research output: Contribution to journalReview article

Kulzer, M, Singhi, AD, Furlan, A, Heller, MT, Katabathina, VS, Mcgrath, KM, Zeh, HJ, Zureikat, A & Dasyam, AK 2018, 'Current concepts in molecular genetics and management guidelines for pancreatic cystic neoplasms: an essential update for radiologists', Abdominal Radiology, vol. 43, no. 9, pp. 2351-2368. https://doi.org/10.1007/s00261-017-1452-5
Kulzer, Matthew ; Singhi, Aatur D. ; Furlan, Alessandro ; Heller, Matthew T. ; Katabathina, Venkata S. ; Mcgrath, Kevin M. ; Zeh, Herbert J. ; Zureikat, Amer ; Dasyam, Anil K. / Current concepts in molecular genetics and management guidelines for pancreatic cystic neoplasms : an essential update for radiologists. In: Abdominal Radiology. 2018 ; Vol. 43, No. 9. pp. 2351-2368.
@article{a47e768220ea48de88e7ed3d7ab75edd,
title = "Current concepts in molecular genetics and management guidelines for pancreatic cystic neoplasms: an essential update for radiologists",
abstract = "Cystic neoplasms in the pancreas are encountered frequently on imaging, often detected incidentally during evaluation for other conditions. They can have a variety of clinical and imaging presentations, and similarly, wide-ranging prognostic and treatment implications. In the majority, imaging helps in diagnosis of pancreatic cystic neoplasms (PCNs) and guides management decisions. But, a significant minority of the PCNs remain indeterminate. There have been multiple recent advances in biomarkers and molecular genetics which will likely prove helpful in risk stratification of PCNs. Several prominent national and international societies, as well as consensus groups have put forth recommendations to help guide management of PCNs. The purpose of this article is to discuss the role of imaging in evaluation of PCNs, review the recent advances in molecular genetics and pancreatic cyst fluid analysis, and analyze the pros and cons of major evidence-based and consensus guidelines for management of PCNs.",
keywords = "IPMN, Mucinous cystadenoma, Pancreatic cystic neoplasm, Serous cystadenoma",
author = "Matthew Kulzer and Singhi, {Aatur D.} and Alessandro Furlan and Heller, {Matthew T.} and Katabathina, {Venkata S.} and Mcgrath, {Kevin M.} and Zeh, {Herbert J.} and Amer Zureikat and Dasyam, {Anil K.}",
year = "2018",
month = "9",
day = "1",
doi = "10.1007/s00261-017-1452-5",
language = "English (US)",
volume = "43",
pages = "2351--2368",
journal = "Abdominal Radiology",
issn = "2366-004X",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Current concepts in molecular genetics and management guidelines for pancreatic cystic neoplasms

T2 - an essential update for radiologists

AU - Kulzer, Matthew

AU - Singhi, Aatur D.

AU - Furlan, Alessandro

AU - Heller, Matthew T.

AU - Katabathina, Venkata S.

AU - Mcgrath, Kevin M.

AU - Zeh, Herbert J.

AU - Zureikat, Amer

AU - Dasyam, Anil K.

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Cystic neoplasms in the pancreas are encountered frequently on imaging, often detected incidentally during evaluation for other conditions. They can have a variety of clinical and imaging presentations, and similarly, wide-ranging prognostic and treatment implications. In the majority, imaging helps in diagnosis of pancreatic cystic neoplasms (PCNs) and guides management decisions. But, a significant minority of the PCNs remain indeterminate. There have been multiple recent advances in biomarkers and molecular genetics which will likely prove helpful in risk stratification of PCNs. Several prominent national and international societies, as well as consensus groups have put forth recommendations to help guide management of PCNs. The purpose of this article is to discuss the role of imaging in evaluation of PCNs, review the recent advances in molecular genetics and pancreatic cyst fluid analysis, and analyze the pros and cons of major evidence-based and consensus guidelines for management of PCNs.

AB - Cystic neoplasms in the pancreas are encountered frequently on imaging, often detected incidentally during evaluation for other conditions. They can have a variety of clinical and imaging presentations, and similarly, wide-ranging prognostic and treatment implications. In the majority, imaging helps in diagnosis of pancreatic cystic neoplasms (PCNs) and guides management decisions. But, a significant minority of the PCNs remain indeterminate. There have been multiple recent advances in biomarkers and molecular genetics which will likely prove helpful in risk stratification of PCNs. Several prominent national and international societies, as well as consensus groups have put forth recommendations to help guide management of PCNs. The purpose of this article is to discuss the role of imaging in evaluation of PCNs, review the recent advances in molecular genetics and pancreatic cyst fluid analysis, and analyze the pros and cons of major evidence-based and consensus guidelines for management of PCNs.

KW - IPMN

KW - Mucinous cystadenoma

KW - Pancreatic cystic neoplasm

KW - Serous cystadenoma

UR - http://www.scopus.com/inward/record.url?scp=85044946067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044946067&partnerID=8YFLogxK

U2 - 10.1007/s00261-017-1452-5

DO - 10.1007/s00261-017-1452-5

M3 - Review article

C2 - 29404638

AN - SCOPUS:85044946067

VL - 43

SP - 2351

EP - 2368

JO - Abdominal Radiology

JF - Abdominal Radiology

SN - 2366-004X

IS - 9

ER -